We have a patient with clinical picture compatible with FKRP-related LGMD2i (aka LGMDr9). Has one known pathogenic mutation and also IVS1+4a>g c.-253+4a. Would like to assess this to better inform clinical decisions about needing a confirmatory biopsy, and possibility address most likely severity of progression.